| 000 | 01490 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516055114.0 | ||
| 264 | 0 | _c20150624 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1520-636X | ||
| 024 | 7 |
_a10.1002/chir.21011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThacker, David L | |
| 245 | 0 | 0 |
_aStereoselective pharmacokinetics of stable isotope (+/-)-[13C]-pantoprazole: Implications for a rapid screening phenotype test of CYP2C19 activity. _h[electronic resource] |
| 260 |
_bChirality _cNov 2011 |
||
| 300 |
_a904-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a2-Pyridinylmethylsulfinylbenzimidazoles _xchemistry |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBreath Tests |
| 650 | 0 | 4 |
_aCarbon Isotopes _xchemistry |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2C19 _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Assays _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPantoprazole |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aModak, Anil | |
| 700 | 1 | _aNguyen, Phuong D | |
| 700 | 1 | _aFlockhart, David A | |
| 700 | 1 | _aDesta, Zeruesenay | |
| 773 | 0 |
_tChirality _gvol. 23 _gno. 10 _gp. 904-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/chir.21011 _zAvailable from publisher's website |
| 999 |
_c21174187 _d21174187 |
||